Cart
sales@molnova.com
Enpp-1-IN-16
Enpp-1-IN-16
Catalog No. M37145
Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 275 | In Stock |
|
| 50MG | 423 | In Stock |
|
| 100MG | 669 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1386 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEnpp-1-IN-16
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1.
molnova catalog
related products
-
Doxofylline
Doxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.
-
Rolipram
A potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
-
PF-8380
Potent autotaxin inhibitor (IC50?= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).
